|
A proposed
refinement of the mitochondrial free radical theory of aging
|
Source
Aubrey D.N.J. de Grey: biographical sketch
Email Aubrey de Grey

Born London, England, 1963
B.A., M.A. and Ph.D., University of Cambridge, Cambridge, UK.
Employment 1992-present: Department of Genetics, University of
Cambridge, Cambridge CB2 3EH, UK
The central goal of my work is to expedite the development of a
true cure for human aging. In my view, the main obstacle to
developing such technology is the position of biogerontology at
the boundary between basic science and medicine: the fundamental
knowledge necessary to develop truly effective anti-aging
medicine mostly exists, but the goal-directed frame of mind that
is best suited to turning research findings into tools is very
different from the curiosity-driven ethos that generated those
findings in the first place. As a scientist with a training in
an engineering discipline (computer science), I am unusually
well placed to bridge this gap. I attempt to do so in three main
ways: I do basic biogerontology research, I identify and promote
specific technological approaches to the reversal (not merely
the prevention) of various aspects of aging, and I argue in a
wide range of fora (extending well beyond biologists) for the
adoption of a more proactive approach to extending the healthy
human lifespan sooner rather than later.
Society memberships:
International Association of Biomedical Gerontology (Board
of Directors)
British Society for Research on Ageing
American Aging Association (Board of Directors)
Gerontological Society of America (Fellow)
Genetics Society of America
Oxidative Stress and Aging Association (Secretary)
International Coenzyme Q10 Association
Mitochondrion Research Society
Journal editorial board memberships:
Rejuvenation Research (editor-in-chief)
Antioxidants and Redox Signaling
Mitochondrion (associate editor)
Speaking engagements: I give an average of 5-10 invited talks
per year at scientific conferences and universities.
|
A proposed refinement of the
mitochondrial free radical theory of aging
Aubrey D. N. J. de Grey
Summary
Over recent years,
evidence has been accumulating in favour of the free radical
theory of aging, first proposed by Harman(1,2).
Despite this, an
understanding of the mechanism by which cells might succumb to the
effects of free radicals has proved elusive.
This paper
proposes such a mechanism, based on a previously unexplored
hypothesis for the proliferation of mutant mitochondrial DNA:
that
mitochondria with reduced respiratory function, due to a mutation
or deletion affecting the respiratory chain, suffer less frequent
lysosomal degradation, because they inflict free radical damage
more slowly on their own membranes.
|
Karl Loren: Here is my
simplified understanding of the above.
Inside the human cell is
something called the "mitochondria." There are actually
several of these inside each cell. Their job is to control the
production of energy inside the cell.
There are parts of the cell
which contain the "blueprint" or "instructions" on how the
cell functions and how it reproduces. When and as this
part gets damaged by a random free radical, the damage might
be to alter the normal function of the larger part in which it
exists.
Thus, there is
|
Once such a
mutation occurs in a mitochondrion of a non-dividing cell,
therefore, mitochondria carrying it will rapidly populate that cell,
thereby destroying the cell's respiratory capability.
The accumulation
of cells that have undergone this transition results in aging at the
organismal level.
The consistency of
the hypothesis with known facts is discussed, and technically
feasible tests are suggested both of the proposed mechanism and of
its overall contribution to mammalian aging.
Introduction
In 1956, Harman(1) published the
first version of the free radical hypothesis of aging, which will be
the topic of this paper. His idea was that a major mechanism of
aging might be the accumulation of damage to macromolecules,
inflicted by free radicals (that is, molecules which carry an
unpaired electron). Subsequently he extended the idea(2) with the
proposal that mitochondria, which had by then been shown to be a
major site of production of oxygen free radicals(3), were also the
major site of free radical damage causing aging. The following
observations are among those supporting this proposal: (a) that the
pigment lipofuscin, which is believed to be the indigestible remnant
of phagocytosed cellular detritus, seems mainly to derive from
mitochondrial membranes(4); (b) that the most harmful free radicals
must, on thermodynamic grounds, do most of their damage very near to
their site of production(5); (c) that aged muscle has reduced
mitochondrial activity(6,7,8); (d) that, to a first approximation,
longevity of different homeotherms varies inversely with their
metabolic rate(9); (e) that species which live longer than their
metabolic rate would predict suffer unusually little mitochondrial
lipid peroxidation, and their mitochondrial membranes also possess
unusually few highly unsaturated fatty acids(10). (These last
results are linked because oxygen free radicals only attack lipids'
C=C bonds, not C-C bonds.)
To this list should be added an item not explicitly supportive of
the above idea, but on which the present paper will draw heavily:
that mitochondria replicate more frequently than their host
cells(11,12). The extreme case is that of cell types which never
divide, such as in heart, skeletal muscle and brain; in rats,
mitochondrial generation time even in these tissues is under a
month(12). This does not result in ever-increasing numbers of
mitochondria per cell, so we can infer that mitochondria are also
broken down at a similar rate. Why is this turnover so rapid? Since
mitochondrial biogenesis is an expensive task, this is a valuable
question to explore.
The remainder of this paper falls
into three parts: (i) a summary of the three main subsequent ideas
that have led to one current version of the free radical hypothesis;
(ii) a hypothesis, which accepts the first and second of those
ideas, suggests an alternative to the last, and extends it; and
(iii) a discussion of the plausibility and testability of that
hypothesis.
Idea 1:
Mitochondrial decline results from
increasing mtDNA dysfunction Mitochondria are alone among mammalian
subcellular organelles in possessing their own DNA (mtDNA), present
in a few copies per mitochondrion. It was not long before
researchers began to ask whether mtDNA mutations play the central
role in the mitochondrial decay that Harman had proposed. Several
items of evidence suggest this: (a) mammalian mtDNA is far more
vulnerable to mutation than nuclear DNA, because (among other
reasons) it has a repeated risk of replication error, which ceases
for nuclear DNA of a postmitotic cell, and it is closer to the main
source of mutagenic free radicals; (b) mt-coded genes are essential
in the respiratory chain and mitochondrial ATP synthesis, but are
unnecessary for mitochondrial or mtDNA replication, so a mutation
can theoretically become homozygous in one or many mitochondria,
through repeated replication and division; (c) no mt-coded proteins
or mRNAs are transferred between mitochondria, so each
mitochondrion's respiratory ability depends on its own mtDNA; (d)
mtDNA deletions and point mutations are both found to accumulate
with age in humans(13,14). (A recent, conflicting report(15)
regarding point mutations is noted below in relation to a proposed
sequence analysis experiment.)
Idea 2:
Increasing mtDNA dysfunction
results from preferential amplification of mutations For researchers
who pursued the idea that free radicals cause mitochondrial decline
by damaging the mtDNA, a natural next question was: does
mitochondrial "competition" play a role in this process? The
mitochondria of a single cell are an isolated population undergoing
replication and destruction, so there is the opportunity for
selective pressure to exist, and supportive evidence has been
reported(16). An alternative hypothesis(17) is that initial
mutations cause a tolerable but significant reduction in the cell's
ATP synthesis capacity, which accelerates the mtDNA mutation rate,
so that eventually all mtDNA suffers deleterious mutations.
Subsequent work lends weight to the selection-based hypothesis(18).
The mitochondria of a single respiration-deficient muscle fibre are
found all to carry the same mutation, and different fibres carry
different mutations. If the means whereby a cell succumbs to mtDNA
mutations were by accelerated mutation rate, we should see the same
range of mutations in each affected cell, irrespective of which
mutation occurred first in a given cell.
Idea 3:
Preferential amplification of
mutations results from their preferential replication Selection for
a deleterious mtDNA mutation can, formally, be achieved in either
(or both) of two ways:
preferential replication of mutant
mitochondria,
or preferential lysosomal
digestion of non-mutant ones.
Hitherto, researchers have focused
on the preferential replication option, but great difficulty has
been encountered in identifying a model, consistent with the
evidence, for how such an advantage might accrue(19,20).
The preferential digestion option is the alternative which underlies
the hypothesis that will now be outlined.
The hypothesis not only seems
consistent with known facts (a question explored in detail in the
"plausibility" section below), but also addresses why, in the first
place, cells engage in the expensive process of frequent
mitochondrial turnover.
The hypothesis: survival of the slowest
The peroxidation and
polymerisation of the lipid molecules of the inner mitochondrial
membrane by free radicals is substantially not repaired. A respiring
mitochondrion will therefore accumulate such damage to its inner
membrane. In due course, the membrane will become unable to perform
its main function, which is the maintenance of the proton gradient
created by the respiratory chain. This will not affect the operation
of the respiratory chain itself, however, only the production of
ATP, so damage will continue. It will eventually be so severe that
proteins escape from the mitochondrion: the outer membrane will not
suffice to prevent this, since
(a) it may itself be somewhat
damaged, and
(b) even if it is not, the smaller
mitochondrial proteins can pass
through its pores.
Many such proteins may be toxic to
cytosolic processes -- they were constructed in the cytosol, but at
that time they were rendered inert by the presence of a leader
peptide, which will by now have been cleaved. The cell removes these
toxins at source, by lysosomal degradation of the damaged
mitochondrion.
Therefore, in order to have any
mitochondria left in the long term, the cell must avert the above
process by maintaining the degree of contamination of its
mitochondrial membranes at a stable level. It achieves this by
degrading some of its mitochondria and replicating others. This
works because the degraded membrane is recycled, and the new
membrane (added to the parent mitochondrion in order to bring it to
a size ready to divide) is pristine. Turnover thus acts to dilute
the existing membrane damage.
It is proposed that this turnover is driven by the toxicity
hypothesised above. Mitochondria accumulate damage until they become
poisonous, and are then digested. Replication occurs when the cell
detects a shortage of ATP, caused directly by the diminished numbers
of mitochondria. Of necessity, the mitochondria that are replicated
are those that have not already been digested.
This situation is stable while all
mitochondria are fully functional. At some point, however, a mtDNA
mutation will inevitably occur that lowers the respiratory
capability of its host mitochondrion. That mitochondrion's lower
level of respiration will translate into a lower concentration of
harmful free radicals in its immediate environment. This will result
in a slower accumulation of damage to its inner membrane than is
occurring in properly respiring ones. Such a mitochondrion will
therefore still be intact when many of the cell's non-mutant
mitochondria have succumbed to the degradation process hypothesised
above. Thus, it will be preferentially replicated. Repetition of
this process will rapidly divest the cell of all its properly
respiring mitochondria (Fig. 1).
Dividing cells must replicate their
mitochondria at least once per cell division, so as to maintain the
number of mitochondria per cell. If cellular division is rapid
enough, there will thus be no significant digestion of mitochondria,
because membrane damage is diluted as fast as it is inflicted. Aging
at the organismal level will therefore not result from this
mechanism in tissues composed of such cell types. In non-dividing or
rarelydividing cell types, however, there will be an accumulation of
ATP-deficient cells leading to aging at the organismal level.
How plausible is this
hypothesis?
The compatibility of this
hypothesis with known facts is now discussed, by analysing several
potential counterarguments.
Antioxidant drugs
A difficulty that has dogged the free radical hypothesis from early
days is the very modest increase in maximum lifespan which results,
in mammals, from antioxidant therapy(2). Recent data give a hint of
why this may be. Simultaneous up-regulation of two major antioxidant
enzymes has been found to bestow longevity benefits in flies(21),
substantially greater than has yet been achieved in mammals; but
previous studies from the same laboratory found that up-regulation
of either one of those enzymes without the other has little such
effect (noted in ref. 21). The authors point out that an organism's
antioxidant system, viewed as a whole, comprises a subtle interplay
of components, whose balance may be crucial to the system's overall
efficacy. This system is much more complex in mammals than in
insects (for example, insects entirely lack glutathione
peroxidase(22)), so the destabilising effect in mammals of
introducing a single antioxidant drug may mask that drug's direct
benefit; it may be very difficult to improve on the defences that
mammals already possess.
Recessiveness of mutations
A second argument is genetic: it
concerns the polyploidy of mitochondria. A single mutated copy of
mtDNA in a mammalian mitochondrion would reduce its copy number of
wildtype DNA only by 10-20%; would this really affect its
respiratory capacity? Indeed, the effect on respiration rate of a
single-copy mutation should be slight. There are two problems with
this challenge, however. Firstly, a small proportion of mutations
will
survive long enough to become homozygous in at least one
mitochondrion, purely through genetic drift, so even complete
recessiveness would not stop the process from taking hold
eventually. Secondly, even a very slight slowing of respiration
should be enough to activate the above mechanism, since the
relationship between respiration rate and chance of survival will
not be linear: in fact, to a first approximation it will be a step
function, as the mitochondrion only needs to survive that little bit
longer than its sisters before being rescued by damage-diluting
division.
Membrane repair in situ
A further potential challenge to
this hypothesis focuses on its initial assertion -- that membrane
damage is substantially not repaired. Indeed, it has been shown(24)
that phospholipase A2 (EC 3.1.1.4), which detaches a fatty acid from
the glycerol of a phospholipid, preferentially targets the more
oxidised regions of membranes. This detached fatty acid can then be
freed from the membrane for degradation or re-reduction elsewhere,
while the lysophospholipid that remains is reacylated by the
attachment of a new, unoxidised fatty acid. Other processes may
exist that excise (or re-reduce in situ) various products of lipid
peroxidation in other ways. However, all such mechanisms can be only
partial solutions, because they must rely, at root, on the
recognition of particular species or families of damaged molecules.
The huge variety of peroxidation products will always include
inter-linked and intra-linked molecules that are intractable to any
of the available selective processes. Such molecules will only
succumb to the blunderbuss approach applied inside a lysosome -- an
approach that would be fatal if attempted in the cytosol. They will
thus inevitably accumulate during a mitochondrion's life, even if
other peroxidation products do not.
Free radical production vs.
free radical damage
Another challenge concerns whether
a respiration-deficient mitochondrion will in fact have a diminished
exposure to free radical damage. This is not obvious, because
certain classes of blockage of the respiratory chain may actually
increase the production of one reactive oxygen species, superoxide.
This is because the leakage of electrons from some of the enzyme
complexes rises when they are in a very reduced state, as those
upstream of the defect will be(25). However, the thermodynamics of
lipid peroxidation, which are well worked out, indicate that
superoxide concentration per se is not relevant. Three major
pathways for initiation of lipid peroxidation are thought to occur,
as summarised in Fig. 2; the reader is referred to ref. 5 for a
thorough overview and to refs. 26-30 for the specifics of certain
reactions. It will be seen that superoxide only initiates lipid
peroxidation when protonated to become perhydroxy radical, a
reaction whose rate varies with the acidity of the medium near the
membrane and is very low at cytosolic pH(5,26). Respiration,
however, creates an excess of protons -- that is, low pH -- on the
outside of the inner membrane. Thus, perhydroxy levels will
necessarily be lower near a mitochondrion that is respiring less.
Another major pathway for initiating lipid peroxidation is
controlled by the availability of ubisemiquinone, which will
likewise be diminished in respiration-deficient mitochondria, in
favour of a predominance of either ubiquinone (if the respiratory
chain components downstream of it are fully functional) or ubiquinol
(if not).
The only pathway that may be
unaffected is the metal-catalysed one, since the relatively stable
H2O2 intermediate has time to diffuse from far away so should be
locally undiminished. Even this may not be so:
when ubiquinol is high, all pathways may in fact be attenuated by
ubiquinol's capacity to reduce lipid peroxyl radicals(27);
conversely, when ubiquinone is high, complex III will be starved of
electrons so less able to leak them to O2.
How can the
hypothesis be tested?
Since the ideas presented here apply most forcefully to non-dividing
cells, D. melanogaster and C. elegans might be thought suitable
model organisms for testing this hypothesis, given that almost all
cells in adults are postmitotic. However, there is reason for
caution. The mechanism presented here can only have an effect if
there are enough mitochondrial generations in the lifetime of the
organism to allow a cell to be taken over by copies of a mutant
mtDNA molecule. Minimally, this is the logarithm to base 2 of the
number of
mitochondrial genomes per cell. Since both the above species live
only a few weeks, a sufficiently short mitochondrial lifetime seems
unlikely; a greater role may be played by the simple efficacy of
antioxidant enzymes, as recent work(21) suggests. Therefore, before
one embarks on tests of whether the process hypothesised in this
paper plays a role in the aging of such short-lived organisms, there
should be a measurement of their rate of mitochondrial turnover, to
establish whether the process can occur at all.
Experiments on dividing tissues
may be able to test this hypothesis, so long as conditions are used
in which the cellular generation time considerably exceeds the
mitochondrial. Chambers and Gingold found in 1986 that
suppressiveness in yeast, which is a notably similar phenomenon to
the process discussed here (in that it entails the preferential
amplification of mitochondria mutant or deficient for respiratory
chain genes), is often not associated with faster replication of the
mutant mtDNA than the wild-type(31). They proposed an explanation
based on non-random segregation in the asymmetric division of a
yeast zygote, but preferential degradation of non-mutants would also
explain this observation. In the same paper, they also reported
(data not shown, but confirmed by Gingold, pers. comm.) that
starvation of a yeast culture markedly increased the levels of
suppressiveness which it exhibited thereafter, independent of
genetic factors. If mitochondria continue to turn over during
starvation, then lysosomal degradation of mitochondria must also
continue, so a mechanism such as proposed here would indeed increase
suppressiveness. It would be valuable to repeat both the above
experiments with human tissue culture cells, to discover whether the
suppressive behaviour already reported in them(16) shares these
features.
A different type of test involves
sequence analysis. Scant attention has been paid in this paper so
far to complex V, the ATP synthetase complex (EC 3.6.1.34). Two of
its components are mitochondrially coded.
If one of them suffers a mutation,
will it be selected for? This hypothesis predicts that it will not,
in view of the pathways initiating lipid peroxidation that were
discussed above and are depicted in Fig. 2. The proton gradient
across the inner membrane of a mitochondrion with an ATP synthetase
mutation (but with an intact respiratory chain) will presumably be
undiminished, so just as much lipid peroxidation will be initiated
by perhydroxy radical. The rate of respiration may be reduced (if
the mutation blocks the passage of protons into the mitochondrion),
but this slow-down would be uniform along the whole respiratory
chain, so the proportion of coenzyme Q that is in the ubisemiquinone
state should be unchanged, so its contribution to lipid damage (via
reaction with H2O2) should also be undiminished. Therefore, this
hypothesis predicts that mutations local to the ATP synthetase
subunits will not be selected for, and thus will not accumulate with
age (unless they somehow block their own transcription: this would
knock out other genes too, since the whole mtDNA is transcribed as
one primary transcript of each strand), whereas mutations in all
other mitochondrially coded genes will accumulate. This test is
particularly strong, because various other theories of mitochondrial
free radical damage predict a uniform distribution of mutations
across all genes. While this paper was in review, a careful study
was published(15) which provisionally confirms the above prediction;
however, a systematic test of it is still motivated.
How can the effect on aging be
tested?
One experiment, of which a variant
has already been suggested by Hoeben(32), stands out as uniquely
direct. It is undoubtedly very ambitious, but the past decade has
brought us a great wealth of experimental evidence on all aspects of
aging at the cellular and macromolecular levels, so its time may
have come. It is to transfect mice with copies of all 13
protein-coding genes of the mtDNA, thereby incorporating them into
the nuclear genome, where they would (as noted earlier) enjoy a
hugely greater degree of protection from mutation. This hypothesis
predicts that mice with these transgenes will, once pitfalls such as
those noted below have been circumvented, exhibit dramatically
slowed aging of muscles, nervous tissue and other non-dividing or
rarelydividing cell types.
This would be a big project, but
it is difficult to dismiss on grounds of practicality.
The disparity of genetic codes can
be corrected by base-pair substitutions, and the regulation of the
products' expression and transport to mitochondria can be addressed
by mimicking the nuclear-coded subunits of the corresponding enzyme
complexes. Nor can the treatment be dismissed as inevitably having
harmful side-effects. The fact that we retain mtDNA does not prove
that we need to, since the differences of genetic code make gene
transfer during evolution extremely difficult. Problems of
stoichiometry may arise, due to simultaneous expression of the
mtcoded and transgenic copies of genes, but this can if necessary be
tackled by, for example, disruption of nuclear-coded components of
the mitochondrial transcription and translation machinery. In view
of this, such a project may realistically be able to create mice
whose mtDNA is both superfluous and harmless to them.
Conclusion
This paper has presented a
hypothesis that extends a long-standing and prominent theory of
aging. Several challenges to the idea's plausibility have been
anticipated and explored, and tests of it proposed. The last of
these tests is a highly ambitious project, which many will consider
wildly premature, but which, if and when even provisionally
successful, would profoundly alter our view of the inevitability of
old age.
Acknowledgements
I thank Bernhard Kadenbach for his
encouragement and support during the refinement of the hypothesis
presented here, and Adelaide Carpenter, Bernard Daunas, Jonathan
Ewbank, Peter Hoeben and Rachel Drysdale for critical reading of the
manuscript. Dr. Carpenter also helped design the figures.
References
1 Harman, D. (1956). Aging: a
theory based on free radical and radiation chemistry. J. Gerontol.
11, 298-300.
2 Harman, D. (1972). The biologic clock: the mitochondria? J. Am.
Geriatr. Soc. 20, 145-147.
3 Pullman, B. (1963). Electronic aspects of biochemistry. Academic
Press, New York.
4 Brunk, U. T. (1989). On the origin of lipofuscin; the iron content
of residual bodies, and the relation of these organelles to the
lysosomal vacuome. A study on cultured human glial cells. Adv. Exp.
Med. Biol. 266, 313-320.
5 Kappus, H. (1985). In Oxidative Stress (ed. H. Sies), pp. 152-195.
Academic Press, New York.
6 Syrovy, I. and Gutmann, E. (1977). Changes in speed of contraction
and ATPase activity in striated muscle during old age. Exp. Gerontol.
12, 31-35.
7 Muller-Hocker, J. (1989). Cytochrome-c-oxidase deficient
cardiomyocytes in the human heart - an age-related phenomenon. A
histochemical ultracytochemical study. Am. J. Pathol. 134,
1167-1173.
8 Boffoli, D., Scacco, S. C.,
Vergari, R., Solarino, G., Santacroce, G. and Papa, S. (1994).
Decline with age of the respiratory chain activity in human skeletal
muscle. Biochim. Biophys. Acta 1226, 73-82.
9 Schmidt-Nielsen, K. (1970).
Energy metabolism, body size, and problems of scaling. Fed. Proc.
29, 1524-1532.
10 Pamplona, R., Prat, J., Cadenas,
S., Rojas, C., Perez-Campo, R., Torres, M. L. and Barja, G . (1996).
Low fatty acid unsaturation protects against lipid peroxidation in
liver mitochondria from long-lived species: the pigeon and human
case. Mech. Ageing Dev. 86, 53-66.
11 Gross, N. J., Getz, G. S. and
Rabinowitz, M. (1969). Apparent turnover of mitochondrial
deoxyribonucleic acid and mitochondrial phospholipids in the tissues
of the rat. J. Biol. Chem. 244, 1552-1562.
12 Menzies, R. A. and Gold, P. H.
(1971). The turnover of mitochondria in a variety of tissues of
young adult and aged rats. J. Biol. Chem. 246, 2425-2429.
13 Munscher, C., Muller-Hocker, J.
and Kadenbach, B. (1993). Human aging is associated with various
point mutations in tRNA genes of mitochondrial DNA. Biol. Chem.
Hoppe Seyler 374, 1099-1104.
14 Kadenbach, B., Munscher, C.,
Frank, V., Muller-Hocker, J. and Napiwotzki, J. (1995). Human aging
is associated with stochastic somatic mutations of mitochondrial
DNA. Mutat. Res. 338, 161-172.
15 Pallotti, F., Chen, X.,
Bonilla, E. and Schon, E. A. (1996). Evidence that specific mtDNA
point mutations may not accumulate in skeletal muscle during normal
human aging. Am. J. Hum. Genet. 59, 591-602.
16 Yoneda, M., Chomyn, A.,
Martinuzzi, A., Hurko, O. and Attardi, G. (1992). Marked replicative
advantage of human mtDNA carrying a point mutation that causes the
MELAS encephalomyopathy. Proc. Natl. Acad. Sci. USA 89,
11164-11168.
17 Arnheim, N. and Cortopassi, G.
(1992). Deleterious mitochondrial DNA mutations accumulate in aging
human tissues. Mutat. Res. 275, 157-167.
18 Muller-Hocker, J., Seibel, P.,
Schneiderbanger, K. and Kadenbach, B. (1993). Different in situ
hybridization patterns of mitochondrial DNA in cytochrome c oxidase-deficient
extraocular muscle fibres in the elderly.
Virchows Arch. (A) 422, 7-15.
19 Gadaleta, M. N., Rainaldi, G.,
Lezza, A. M., Milella, F., Fracasso, F. and Cantatore, P. (1992).
Mitochondrial DNA copy number and mitochondrial DNA deletion in
adult and senescent rats. Mutat. Res. 275, 181-193.
20 Wallace, D. C., Bohr, V. A.,
Cortopassi, G., Kadenbach, B., Linn, S., Linnane, A. W., Richter, C.
and Shay, J. W. (1995). In Molecular Aspects of Aging (ed. K. Esser
and G.M. Martin), pp. 199-225. John Wiley & Sons, Chichester, UK.
21 Orr, W. C. and Sohal, R. S.
(1994). Extension of life-span by overexpression of superoxide
dismutase and catalase in Drosophila melanogaster. Science 263,
1128-1130.
22 Smith, J. and Shrift, A.
(1979). Phylogenetic distribution of glutathione peroxidase. Comp.
Biochem. Physiol. B 63, 39-44.
23 Clayton, D. A., Doda, J. N. and
Friedberg, E. C. (1974). The absence of a pyrimidine dimer repair
mechanism in mammalian mitochondria. Proc. Natl. Acad. Sci. USA 71,
2777-2781.
24 Sevanian, A. and Kim, E.
(1985). Phospholipase A2-dependent release of fatty acids from
peroxidized membranes. J. Free Radic. Biol. Med. 1, 263-271.
25 Sohal, R. S. and Brunk, U. T.
(1992). Mitochondrial production of pro-oxidants and cellular
senescence. Mutat. Res. 275, 295-304.
26 Bielski, B. H., Arudi, R. L.
and Sutherland, M. W. (1983). A study of the reactivity of HO2/O2-
with unsaturated fatty acids. J. Biol. Chem. 258, 4759-4761.
27 Frei, B., Kim, M. C. and Ames,
B. N. (1990). Ubiquinol-10 is an effective lipid-soluble antioxidant
at physiological concentrations. Proc. Natl. Acad. Sci. USA 87,
4879-4883.
28 Cadenas, E. and Boveris, A.
(1980). Enhancement of hydrogen peroxide formation by protophores
and ionophores in antimycin-supplemented mitochondria. Biochem. J.
188, 31-37.
29 Nohl, H. (1990). Is redox-cycling
ubiquinone involved in mitochondrial oxygen activation? Free Radic.
Res. Commun. 8, 307-315.
30 Nohl, H., Gille, L., Schonheit,
K. and Yang, L. (1996). Conditions allowing redox-cycling
ubisemiquinone in mitochondria to establish a direct redox couple
with molecular oxygen. Free Radic. Biol. Med. 20, 207-213.
31 Chambers, P. and Gingold, E.
(1986). A direct study of the relative synthesis of petite and
grande mitochondrial DNA in zygotes from crosses involving
suppressive petite mutants of Saccharomyces cerevisiae. Curr. Genet.
10, 565-571.
32 Hoeben, P. (1993). Possible
reversal of ageing and other mitochondrial deficiencies through
retroviral transfection of mitochondrially encoded proteins to the
nucleus. Med. Hypotheses 41, 131-133.
Aubrey de Grey is at the
Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB23EH, UK. E-mail:
ag24@gen.cam.ac.uk
Fig. 1. Overview of the hypothesis. Once a mutation arises, it may
become fixed; if it does, it is amplified by rarer than average
lysosomal degradation, to the detriment of the cell's overall supply
of ATP. Red circles:
mtDNA molecules. L: lysosome. N: nucleus. Black spots: membrane
lesions. Crosses: mtDNA mutations.
Blue dots: ATP density.
Fig. 2. Principal paths of
unpaired electrons from the respiratory chain to lipids. The steps
marked "*" are those most certain to be attenuated by the localised
chemical changes in and near the inner membrane of a
non-respiring mitochondrion. Only the step marked "*!*" may be
amplified.
This
web site is a breath
of fresh air in a world of pollution.
|